NCT06331260View on ClinicalTrials.gov

Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2028

Study Completion Date

April 1, 2028

Conditions
Liver TransplantationHepatocellular CarcinomaAlpha-FetoproteinProtein Induced by Vitamin K Absence or Antagonist-II
All Listed Sponsors
collaborator

Shulan (Hangzhou) Hospital

OTHER

lead

Zhejiang University

OTHER